Purification of total IgG from sars-cov-2 convalescent serum

  • Arfat Lusinanto UDD Pusat PMI
  • Ria Syafitri Evi Gantini Humanitarian Service Academy, Indonesian Red Cross, Jakarta, Indonesia
  • Dwirini Retno Gunarti Department of Biochemistry and Molecular Biology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
  • Mohamad Sadikin Department of Biochemistry and Molecular Biology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
Keywords: convalescent serum, IgG purification, affinity chromatography, SARS-CoV-2

Abstract

Background: Convalescent plasma contains neutralizing antibodies against SARS-CoV-2 but also potentially harmful inflammatory cytokines. Purified immunoglobulin G fractions offer a safer therapeutic alternative by concentrating antibodies while removing inflammatory mediators.

Objective: To establish a systematic protocol for purifying total IgG from SARS-CoV-2 convalescent serum using sequential chromatographic techniques.

Methods: Serum from 90 recovered donors was pooled into three independent samples. Purification employed four sequential steps: ammonium sulfate precipitation (50% saturation), Sephadex G-100 size-exclusion chromatography, DEAE-Cellulose ion-exchange chromatography, and Protein A affinity chromatography. Purity was assessed by native polyacrylamide gel electrophoresis and radial immunodiffusion.

Results: Starting from serum with 19.68 ± 7.27 mg/mL IgG and 110.47 ± 11.99 mg/mL total protein, the four-step purification yielded final IgG concentration of 1.14 ± 0.70 mg/mL with 1.19 ± 0.16 mg/mL total protein. This achieved 6.3-fold purification with purity ratio of 1.01 ± 0.38 and 5.8% recovery. Native PAGE confirmed high purity with a single IgG band.

Conclusion: Sequential chromatography successfully purified total IgG from convalescent serum, providing a laboratory-scale method for preparing safer immunoglobulin therapeutics.

References

Bermejo-Martin JF, Avila-Alonso A, González-Rivera M, Tamayo E, Eiros JM, Almansa R. Postbooster antibodies from humans as source of diphtheria antitoxin. Emerg Infect Dis. 2016;22: 1265-1267. https://doi.org/10.3201/eid2207.151670

IHE. Criteria for the Clinical Use of Immune Globulin. 2nd ed. Institute of Heath Economics; 2022.

Misset B, Piagnerelli M, Hoste E, Dardenne N, Grimaldi D, Michaux I, et al. Convalescent plasma for Covid-19-induced ARDS in mechanically ventilated patients. N Engl J Med. 2023;389: 1590-1600. https://doi.org/10.1056/NEJMoa2209502

Hsu R-J, Yu W-C, Peng G-R, Ye C-H, Hu S, Chong PCT, et al. The role of cytokines and chemokines in severe acute respiratory syndrome Coronavirus 2 infections. Front Immunol. 2022;13: 832394. https://doi.org/10.3389/fimmu.2022.832394

Chang CE, Eo HG, Lee YS, Chung SK, Shin J S and Lah YK, Park CW, et al. Human intravenous immunoglobulin preparation and virus inactivation by pasteurization and solvent detergent treatment. Prep Biochem Biotechnol. 2000;30: 177-197. https://doi.org/10.1080/10826060008544957

Buchacher A, Iberer G. Purification of intravenous immunoglobulin G from human plasma-aspects of yield and virus safety. Biotechnol J. 2006;1: 148-163. https://doi.org/10.1002/biot.200500037

Parkkinen J, Rahola A, von Bonsdorff L, Tölö H, Törmä E. A modified caprylic acid method for manufacturing immunoglobulin G from human plasma with high yield and efficient virus clearance. Vox Sang. 2006;90: 97-104. https://doi.org/10.1111/j.1423-0410.2005.00731.x

Winiger RR, Perez L. Therapeutic antibodies and alternative formats against SARS-CoV-2. Antiviral Res. 2024;223: 105820. https://doi.org/10.1016/j.antiviral.2024.105820

King HAD, Dussupt V, Mendez-Rivera L, Slike BM, Tran U, Jackson ND, et al. Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters. Front Immunol. 2023;14: 1138629. https://doi.org/10.3389/fimmu.2023.1138629

Cohn EJ, Strong LE, Hughes WL, Mulford DJ, Ashworth JN, Melin M, et al. Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids^1a,b,c,d. J Am Chem Soc. 1946;68: 459-475. https://doi.org/10.1021/ja01207a034

O'Kennedy R, Murphy C, Devine T. Technology advancements in antibody purification. Antib Technol J. 2016;6: 17-32. https://doi.org/10.2147/ANTI.S64762

O'Halloran DP, Wynne K, Geoghegan JA. Protein A is released into the Staphylococcus aureus culture supernatant with an unprocessed sorting signal. Infect Immun. 2015;83: 1598-1609. https://doi.org/10.1128/IAI.03122-14

Mane V, Mehta R, Alvarez N, Sharma V, Park S, Fox A, et al. In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19. Hum Vaccin Immunother. 2024;20: 2303226. https://doi.org/10.1080/21645515.2024.2303226

Warburg O, Christian W. Isolierung und Kristallisation des Garungs ferments Enolase. Biochem Z. 1941;310: 384-421.

Shanmugam S, Kumar TS, Panner Selvam K. Laboratory Handbook on Biochemistry. PHI; 2019.

Mudjihartini N, Andayani DE, Prasetya SI, Sadikin M. Total protein, secretory immunoglobulin A and lactoferrin concentrations in the breastmilk of lactating women and their correlation with nutritional intake. Int J Med Biomed Stud. 2022;6. https://doi.org/10.32553/ijmbs.v6i4.2501

Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965;2: 235-254. https://doi.org/10.1016/0019-2791(65)90004-2

Bayry J, Ahmed EA, Toscano-Rivero Diana and Vonniessen N, Genest G, Cohen CG, Dembele M, et al. Intravenous immunoglobulin: Mechanism of action in autoimmune and inflammatory conditions. J Allergy Clin Immunol Pract. 2023;11: 1688-1697. https://doi.org/10.1016/j.jaip.2023.04.002

Almizraq RJ, Branch DR. Efficacy and mechanism of intravenous immunoglobulin treatment for immune thrombocytopenia in adults. Ann Blood. 2021;6: 2. https://doi.org/10.21037/aob-20-87

Parker AR, Skold M, Ramsden DB, Ocejo-Vinyals JG, López-Hoyos M, Harding S. The clinical utility of measuring IgG subclass immunoglobulins during immunological investigation for suspected primary antibody deficiencies. Lab Med. 2017;48: 314-325. https://doi.org/10.1093/labmed/lmx058

Published
2025-12-05
How to Cite
Lusinanto, A., Gantini, R. S. E., Gunarti, D. R., & Sadikin, M. (2025). Purification of total IgG from sars-cov-2 convalescent serum. Acta Biochimica Indonesiana, 8(2), 203. https://doi.org/10.32889/actabioina.203